vs
Coeur Mining, Inc.（CDE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Coeur Mining, Inc.的季度营收约是Royalty Pharma plc的1.1倍（$674.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 31.9%，领先2.6%），Coeur Mining, Inc.同比增速更快（120.9% vs 4.8%），过去两年Coeur Mining, Inc.的营收复合增速更高（78.0% vs 4.6%）
Coeur Mining, Inc.是纽交所上市的贵金属开采企业，在北美运营五座矿山，拥有员工2200名。2012年该公司为全球第九大白银生产商，2013年由原名称Coeur d'Alene Mines正式更名，总部也从爱达荷州科达伦迁至伊利诺伊州芝加哥。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CDE vs RPRX — 直观对比
营收规模更大
CDE
是对方的1.1倍
$622.0M
营收增速更快
CDE
高出116.2%
4.8%
净利率更高
RPRX
高出2.6%
31.9%
两年增速更快
CDE
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $674.8M | $622.0M |
| 净利润 | $215.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 48.6% | 62.4% |
| 净利率 | 31.9% | 34.4% |
| 营收同比 | 120.9% | 4.8% |
| 净利润同比 | 467.9% | 2.9% |
| 每股收益（稀释后） | $0.37 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDERPRX
| Q4 25 | $674.8M | $622.0M | ||
| Q3 25 | $554.6M | $609.3M | ||
| Q2 25 | $480.6M | $578.7M | ||
| Q1 25 | $360.1M | $568.2M | ||
| Q4 24 | $305.4M | $593.6M | ||
| Q3 24 | $313.5M | $564.7M | ||
| Q2 24 | $222.0M | $537.3M | ||
| Q1 24 | $213.1M | $568.0M |
净利润CDERPRX
| Q4 25 | $215.0M | $214.2M | ||
| Q3 25 | $266.8M | $288.2M | ||
| Q2 25 | $70.7M | $30.2M | ||
| Q1 25 | $33.4M | $238.3M | ||
| Q4 24 | $37.9M | $208.2M | ||
| Q3 24 | $48.7M | $544.0M | ||
| Q2 24 | $1.4M | $102.0M | ||
| Q1 24 | $-29.1M | $4.8M |
营业利润率CDERPRX
| Q4 25 | 48.6% | 62.4% | ||
| Q3 25 | 31.9% | 70.1% | ||
| Q2 25 | 29.1% | 36.3% | ||
| Q1 25 | 17.3% | 94.0% | ||
| Q4 24 | 21.8% | 60.9% | ||
| Q3 24 | 26.9% | — | ||
| Q2 24 | 7.5% | 50.2% | ||
| Q1 24 | -1.6% | -13.0% |
净利率CDERPRX
| Q4 25 | 31.9% | 34.4% | ||
| Q3 25 | 48.1% | 47.3% | ||
| Q2 25 | 14.7% | 5.2% | ||
| Q1 25 | 9.3% | 41.9% | ||
| Q4 24 | 12.4% | 35.1% | ||
| Q3 24 | 15.5% | 96.3% | ||
| Q2 24 | 0.6% | 19.0% | ||
| Q1 24 | -13.7% | 0.8% |
每股收益（稀释后）CDERPRX
| Q4 25 | $0.37 | $0.49 | ||
| Q3 25 | $0.41 | $0.67 | ||
| Q2 25 | $0.11 | $0.07 | ||
| Q1 25 | $0.06 | $0.55 | ||
| Q4 24 | $0.11 | $0.46 | ||
| Q3 24 | $0.12 | $1.21 | ||
| Q2 24 | $0.00 | $0.23 | ||
| Q1 24 | $-0.08 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $553.6M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.3B | $9.7B |
| 总资产 | $4.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CDERPRX
| Q4 25 | $553.6M | $618.7M | ||
| Q3 25 | $266.3M | $938.9M | ||
| Q2 25 | $111.6M | $631.9M | ||
| Q1 25 | $77.6M | $1.1B | ||
| Q4 24 | $55.1M | $929.0M | ||
| Q3 24 | $76.9M | $950.1M | ||
| Q2 24 | $74.1M | $1.8B | ||
| Q1 24 | $67.5M | $843.0M |
总债务CDERPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CDERPRX
| Q4 25 | $3.3B | $9.7B | ||
| Q3 25 | $3.1B | $9.6B | ||
| Q2 25 | $2.8B | $9.5B | ||
| Q1 25 | $2.7B | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.1B | $10.3B | ||
| Q2 24 | $1.0B | $9.8B | ||
| Q1 24 | $1.0B | $9.9B |
总资产CDERPRX
| Q4 25 | $4.7B | $19.6B | ||
| Q3 25 | $4.5B | $19.3B | ||
| Q2 25 | $4.2B | $18.3B | ||
| Q1 25 | $4.1B | $17.6B | ||
| Q4 24 | $2.3B | $18.2B | ||
| Q3 24 | $2.2B | $18.0B | ||
| Q2 24 | $2.1B | $17.7B | ||
| Q1 24 | $2.1B | $16.1B |
负债/权益比CDERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $374.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $313.3M | — |
| 自由现金流率自由现金流/营收 | 46.4% | — |
| 资本支出强度资本支出/营收 | 9.1% | — |
| 现金转化率经营现金流/净利润 | 1.74× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $665.7M | — |
8季度趋势，按日历期对齐
经营现金流CDERPRX
| Q4 25 | $374.6M | $827.1M | ||
| Q3 25 | $237.7M | $702.6M | ||
| Q2 25 | $207.0M | $364.0M | ||
| Q1 25 | $67.6M | $596.1M | ||
| Q4 24 | $63.8M | $742.5M | ||
| Q3 24 | $111.1M | $703.6M | ||
| Q2 24 | $15.2M | $658.2M | ||
| Q1 24 | $-15.9M | $664.6M |
自由现金流CDERPRX
| Q4 25 | $313.3M | — | ||
| Q3 25 | $188.7M | — | ||
| Q2 25 | $146.1M | — | ||
| Q1 25 | $17.6M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $69.1M | — | ||
| Q2 24 | $-36.2M | — | ||
| Q1 24 | $-58.0M | — |
自由现金流率CDERPRX
| Q4 25 | 46.4% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 30.4% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | -27.2% | — |
资本支出强度CDERPRX
| Q4 25 | 9.1% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 13.4% | — | ||
| Q2 24 | 23.2% | — | ||
| Q1 24 | 19.8% | — |
现金转化率CDERPRX
| Q4 25 | 1.74× | 3.86× | ||
| Q3 25 | 0.89× | 2.44× | ||
| Q2 25 | 2.93× | 12.06× | ||
| Q1 25 | 2.03× | 2.50× | ||
| Q4 24 | 1.69× | 3.57× | ||
| Q3 24 | 2.28× | 1.29× | ||
| Q2 24 | 10.69× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDE
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
